Insulin resistance and cardiovascular disease

CE Kosmas, MD Bousvarou… - Journal of …, 2023 - journals.sagepub.com
Insulin resistance (IR) and cardiovascular disease (CVD) represent two universal public
health hazards, especially in today's Western societies. A causal-effect relationship has …

Effects of fetuin-A with diverse functions and multiple mechanisms on human health

MA Icer, H Yıldıran - Clinical biochemistry, 2021 - Elsevier
Abstract Fetuin-A (Alfa 2-Heremans-Schmid) is a glycoprotein that is mainly synthesized by
hepatocytes and then released into the bloodstream. While fetuin-A, a multifunctional …

[HTML][HTML] Crucial Regulatory Role of Organokines in relation to metabolic changes in non-diabetic obesity

H Lőrincz, S Somodi, B Ratku, M Harangi, G Paragh - Metabolites, 2023 - mdpi.com
Obesity is characterized by an excessive accumulation of fat leading to a plethora of medical
complications, including coronary artery disease, hypertension, type 2 diabetes mellitus or …

[HTML][HTML] Low Levels of Serum Fetuin-A and Retinol-Binding Protein 4 Correlate with Lipoprotein Subfractions in Morbid Obese and Lean Non-Diabetic Subjects

H Lőrincz, I Csige, M Harangi, A Szentpéteri, I Seres… - Life, 2021 - mdpi.com
Background: Fetuin-A and retinol-binding protein 4 (RBP4) are secreted as both hepatokine
and adipokine. These are involved in insulin resistance, obesity-related dyslipidemia, and …

[HTML][HTML] Impact of bisphenol a on the levels of vascular calcification biomarkers in type 2 diabetes mellitus with vascular complications: A case-control study

M Nehru, P Subramaniam, MS Jancy, P Durairaj… - Emerging …, 2024 - Elsevier
Bisphenol A (BPA) is an endocrine disruptor present in polycarbonate plastics used in food
containers and water bottles that resists insulin action and leads to type 2 diabetes mellitus …

[HTML][HTML] Hepatokines Fetuin-A and Fetuin-B status in obese Saudi patient with diabetes mellitus type 2

O Almarashda, S Abdi, S Yakout… - American Journal of …, 2022 - ncbi.nlm.nih.gov
The present study aims to investigate the association of the serum levels of Fetuin-A and
Fetuin-B with type 2 diabetes mellitus (T2DM) in obese Saudi patients and explore the …

[HTML][HTML] Decreased insulin resistance in diabetic patients by influencing Sirtuin1 and Fetuin-A following supplementation with ellagic acid: a randomized controlled …

M Ghadimi, F Foroughi, S Hashemipour… - Diabetology & Metabolic …, 2021 - Springer
Background The beneficial effects of polyphenols have been reported. This study aimed to
investigate the effect of oral Ellagic acid (EA) supplement on insulin resistance (IR) and …

[HTML][HTML] Apigenin targets fetuin-A to ameliorate obesity-induced insulin resistance

MC Hsu, CH Chen, MC Wang, WH Chen, PA Hu… - International Journal of …, 2024 - ijbs.com
Fetuin-A, a hepatokine secreted by hepatocytes, binds to insulin receptors and consequently
impairs the activation of the insulin signaling pathway, leading to insulin resistance …

Association between insulin resistance and BMI with FEV1 in non‐hypoxemic COPD out‐patients

FF Zuberi, N Bader, T Rasheed… - The clinical respiratory …, 2021 - Wiley Online Library
Objectives This study was conducted to determine the impact of insulin resistance using
Homeostatic Model Assessment of Insulin Resistance (HOMA‐IR) score and BMI in non …

[HTML][HTML] GLP-1 receptor agonists modulate blood glucose levels in T2DM by affecting Faecalibacterium prausnitzii abundance in the intestine

L Liang, E Rao, X Zhang, B Wu, X Su, L Chen, R Nie… - Medicine, 2023 - journals.lww.com
Background: Glucagon-like peptide 1 (GLP-1) receptor agonists are a class of medications
used to treat type 2 diabetes, including metformin, which is considered first-line therapy for …